Elsaie ML, Hanafy NS, Hussein SM, Abou Zeid OO, Zaky MS, Eldahshan RM, Nada HA, Sayedahmed O, El Zawahry YB. Prevalence of Female Sexual Dysfunction Among Psoriatic Females: A Cross Sectional Case Controlled Study.
Dermatol Pract Concept 2023;
13:e2023209. [PMID:
37557143 PMCID:
PMC10412072 DOI:
10.5826/dpc.1303a209]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/23/2023] [Indexed: 08/11/2023] Open
Abstract
INTRODUCTION
Sexual relationships are an integral part of females psychological and physiological wellbeing.
OBJECTIVES
The study aimed to identify prevalence and impact of Female Sexual Dysfunction (FSD) in women affected with psoriasis.
METHODS
This cross-sectional study was carried out on 150 married females who were interviewed to answer Female Sexual Function Index (FSFI) questionnaire and were divided into two groups: the first group included 100 female patients complaining of psoriasis (50 suffering from moderate psoriasis and 50 with severe psoriasis). The disease severity was graded according to the Psoriasis Area and Severity Index (PASI) while the second group included 50 age matched women who served as controls.
RESULTS
Female sexual dysfunction (FSD) in psoriasis female groups was higher than that in the control group (47%, 24%, P < 0.05). The mean total scores of FSFI ranged from 12.30 to 34.20 and were significantly lower in the severe PASI affected group (22.34 ± 5.35) when compared to moderate PASI group (26.24 ± 2.67) or control group (28.79 ± 2.22). In addition, total scores were significantly lower among moderate PASI affected females when compared to control group.
CONCLUSIONS
Sexual dysfunction should be routinely investigated in female patients with psoriasis in the case of moderate-severe disease due to its negative impact on quality of life. Further research over the effect of certain interventional programs on FSD should be considered for patients suffering from psoriasis.
Collapse